发布求助
文献互助 智能选刊 最新文献

Enfermedad Inflamatoria Intestinal al Día最新文献

筛选
英文 中文
Manejo perioperatorio de la enfermedad inflamatoria intestinal 炎症性肠病的围手术期管理
Enfermedad Inflamatoria Intestinal al Día Pub Date : 2015-09-01 DOI: 10.1016/j.eii.2015.08.003
J. de Oca , F. Rodríguez-Moranta , E. de Lama , J. Guardiola
{"title":"Manejo perioperatorio de la enfermedad inflamatoria intestinal","authors":"J. de Oca ,&nbsp;F. Rodríguez-Moranta ,&nbsp;E. de Lama ,&nbsp;J. Guardiola","doi":"10.1016/j.eii.2015.08.003","DOIUrl":"10.1016/j.eii.2015.08.003","url":null,"abstract":"<div><h3>Introduction</h3><p>An important percentage of patients with inflammatory bowel disease will require surgical treatment at some point. Despite technological progress in the surgical and anaesthetic fields, figures for postoperative morbidity are still high. This alone requires a comprehensive review of perioperative protocols that will allow better surgical results.</p></div><div><h3>Objective</h3><p>To update all organisational and therapeutic measures that have proven to be effective when it comes to optimising the perioperative period.</p></div><div><h3>Methods</h3><p>Review of literature related to postoperative morbidity, immunosupression, radiology, nutrition, multidisciplinary teams and multimodal rehabilitation protocols.</p></div><div><h3>Results</h3><p>Management of inflammatory bowel disease, especially during the perioperative period, requires the coordinated action of a multidisciplinary team with a specific dedication to this condition. The surgical decision must be agreed upon clinical criteria and reinforced by means of modern imaging techniques. Sepsis, malnutrition and prolonged corticoid therapy have shown to be the principal determining factors for morbimortality after surgery. The presence of an abscess requires percutaneous drainage followed by surgery. Malnutrition states require aggressive nutritional therapy before the surgery and, whenever possible, the corticoid dosage should be reduced. Compliance with the current ERAS multimodal rehabilitation protocols can help shorten the admission period after surgery and offer an efficient and viable alternative for improving the postoperative period and the quality of life for patients.</p></div>","PeriodicalId":100473,"journal":{"name":"Enfermedad Inflamatoria Intestinal al Día","volume":"14 3","pages":"Pages 87-93"},"PeriodicalIF":0.0,"publicationDate":"2015-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.eii.2015.08.003","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79450767","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Manifestaciones tromboembólicas en enfermedad inflamatoria intestinal 炎症性肠病的血栓栓塞表现
Enfermedad Inflamatoria Intestinal al Día Pub Date : 2015-09-01 DOI: 10.1016/j.eii.2015.08.002
A. Campos Ruiz , P. Ramirez de la Piscina Urraca , I. Ganchegui Aguirre , L. Urtasun Arlegui , A. Sanchez Patón , K. Spicakova , I.M. Duca Duca , S. Estrada Oncins , E. Delgado Fontaneda , M. Salvador Perez , B. Rodriguez Vigil
{"title":"Manifestaciones tromboembólicas en enfermedad inflamatoria intestinal","authors":"A. Campos Ruiz ,&nbsp;P. Ramirez de la Piscina Urraca ,&nbsp;I. Ganchegui Aguirre ,&nbsp;L. Urtasun Arlegui ,&nbsp;A. Sanchez Patón ,&nbsp;K. Spicakova ,&nbsp;I.M. Duca Duca ,&nbsp;S. Estrada Oncins ,&nbsp;E. Delgado Fontaneda ,&nbsp;M. Salvador Perez ,&nbsp;B. Rodriguez Vigil","doi":"10.1016/j.eii.2015.08.002","DOIUrl":"10.1016/j.eii.2015.08.002","url":null,"abstract":"<div><p>Inflammatory bowel disease (IBD) is a systemic chronic disease, which in some cases is associated with thromboembolic events. Although these events are uncommon, they are increased in patients with IBD and increase morbidity and mortality.While IBD is active there are modifications in the coagulation system, thus inducing a hypercoagulable state and a risk of developing thrombotic events which are not present in patients with inactive IBD.It is essential to identify which patients have a higher risk of developing a thrombotic event and establish appropriate prophylaxis as early as possible.We present some cases of patients diagnosed with IBD who developed vascular complications in the course of their disease and we review the existing literature.</p></div>","PeriodicalId":100473,"journal":{"name":"Enfermedad Inflamatoria Intestinal al Día","volume":"14 3","pages":"Pages 81-86"},"PeriodicalIF":0.0,"publicationDate":"2015-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.eii.2015.08.002","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78192477","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cómo los estudios traslacionales asociados a ensayos clínicos pueden mejorar nuestro conocimiento de las enfermedades inflamatorias 与临床试验相关的转化研究如何提高我们对炎症疾病的认识
Enfermedad Inflamatoria Intestinal al Día Pub Date : 2015-09-01 DOI: 10.1016/j.eii.2015.08.001
J. Panés
{"title":"Cómo los estudios traslacionales asociados a ensayos clínicos pueden mejorar nuestro conocimiento de las enfermedades inflamatorias","authors":"J. Panés","doi":"10.1016/j.eii.2015.08.001","DOIUrl":"10.1016/j.eii.2015.08.001","url":null,"abstract":"","PeriodicalId":100473,"journal":{"name":"Enfermedad Inflamatoria Intestinal al Día","volume":"14 3","pages":"Pages 79-80"},"PeriodicalIF":0.0,"publicationDate":"2015-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.eii.2015.08.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76435682","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recomendaciones del Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU) sobre el cribado y tratamiento de la tuberculosis latente en pacientes con enfermedad inflamatoria intestinal 西班牙克罗恩病和溃疡性结肠炎工作组(GETECCU)关于炎症性肠疾病患者潜伏结核病的筛查和治疗的建议
Enfermedad Inflamatoria Intestinal al Día Pub Date : 2015-09-01 DOI: 10.1016/j.eii.2015.09.001
S. Riestra , C. Taxonera , D. Carpio , A. López-San Román , J.P. Gisbert , E. Domènech , en representación de GETECCU
{"title":"Recomendaciones del Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU) sobre el cribado y tratamiento de la tuberculosis latente en pacientes con enfermedad inflamatoria intestinal","authors":"S. Riestra ,&nbsp;C. Taxonera ,&nbsp;D. Carpio ,&nbsp;A. López-San Román ,&nbsp;J.P. Gisbert ,&nbsp;E. Domènech ,&nbsp;en representación de GETECCU","doi":"10.1016/j.eii.2015.09.001","DOIUrl":"10.1016/j.eii.2015.09.001","url":null,"abstract":"<div><p>The use of antibodies against tumor necrosis factor alpha (anti-TNF) increases the risk of tuberculosis (TB) in patients with inflammatory bowel diseases (IBD). The Spanish Working Group in IBD (GETECCU) developed the first guidelines for TB screening in IBD in 2003, and they were further reviewed in 2006. However, the widespread use in clinical practice of new diagnostic tools such as interferon-gamma release assays, the better knowledge of epidemiological and clinical features of TB in the setting of anti-TNF therapy, and the evidence that TB has decreased but still occurs despite the implementation of guidelines for the screening of latent TB infection, prompted a new revision of the GETECCU recommendations.</p></div>","PeriodicalId":100473,"journal":{"name":"Enfermedad Inflamatoria Intestinal al Día","volume":"14 3","pages":"Pages 109-119"},"PeriodicalIF":0.0,"publicationDate":"2015-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.eii.2015.09.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87331770","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
Más allá de la curación mucosa endoscópica en la colitis ulcerosa: la remisión histológica predice mejor la utilización de corticoides y la necesidad de hospitalización durante 6 años de seguimiento 溃疡性结肠炎的内镜粘膜愈合之外:组织学缓解更好地预测了皮质类固醇的使用和6年随访的住院需要
Enfermedad Inflamatoria Intestinal al Día Pub Date : 2015-09-01 DOI: 10.1016/j.eii.2015.08.005
D. Carpio
{"title":"Más allá de la curación mucosa endoscópica en la colitis ulcerosa: la remisión histológica predice mejor la utilización de corticoides y la necesidad de hospitalización durante 6 años de seguimiento","authors":"D. Carpio","doi":"10.1016/j.eii.2015.08.005","DOIUrl":"10.1016/j.eii.2015.08.005","url":null,"abstract":"","PeriodicalId":100473,"journal":{"name":"Enfermedad Inflamatoria Intestinal al Día","volume":"14 3","pages":"Pages 120-123"},"PeriodicalIF":0.0,"publicationDate":"2015-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.eii.2015.08.005","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83467479","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comentarios sobre estudios multicéntricos aleatorizados para colitis ulcerosa en fase IIa IIa期溃疡性结肠炎随机多中心研究综述
Enfermedad Inflamatoria Intestinal al Día Pub Date : 2015-05-01 DOI: 10.1016/j.eii.2015.05.001
A. Gutiérrez Casbas
{"title":"Comentarios sobre estudios multicéntricos aleatorizados para colitis ulcerosa en fase IIa","authors":"A. Gutiérrez Casbas","doi":"10.1016/j.eii.2015.05.001","DOIUrl":"10.1016/j.eii.2015.05.001","url":null,"abstract":"","PeriodicalId":100473,"journal":{"name":"Enfermedad Inflamatoria Intestinal al Día","volume":"14 2","pages":"Pages 76-78"},"PeriodicalIF":0.0,"publicationDate":"2015-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.eii.2015.05.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91489775","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recomendaciones sobre el uso e indicaciones del tratamiento tópico en pacientes con colitis ulcerosa 溃疡性结肠炎患者局部治疗的使用建议和适应症
Enfermedad Inflamatoria Intestinal al Día Pub Date : 2015-05-01 DOI: 10.1016/j.eii.2015.06.002
D. Ginard , I. Marín-Jiménez , M. Barreiro de Acosta , E. Ricart , E. Domènech , J.P. Gisbert , M. Esteve , M. Mínguez , en representación de GETECCU
{"title":"Recomendaciones sobre el uso e indicaciones del tratamiento tópico en pacientes con colitis ulcerosa","authors":"D. Ginard ,&nbsp;I. Marín-Jiménez ,&nbsp;M. Barreiro de Acosta ,&nbsp;E. Ricart ,&nbsp;E. Domènech ,&nbsp;J.P. Gisbert ,&nbsp;M. Esteve ,&nbsp;M. Mínguez ,&nbsp;en representación de GETECCU","doi":"10.1016/j.eii.2015.06.002","DOIUrl":"https://doi.org/10.1016/j.eii.2015.06.002","url":null,"abstract":"<div><p>Although most patients with ulcerative colitis should be treated with topical treatment, different studies have shown that they are underused. The purpose of this article is to answer 10 specific questions about which drugs are available for topical use in the treatment of ulcerative colitis, and their characteristics in terms of formulation, dosage, presentation, application and proximal distribution of rectal-administered drugs. The efficacy of the available topical drugs and the benefits of combining different formulations and routes of administration, and their usefulness during disease remission is evaluated. Finally, some recommendations are given to better inform patients about the proper implementation and administration of topical treatment.</p></div>","PeriodicalId":100473,"journal":{"name":"Enfermedad Inflamatoria Intestinal al Día","volume":"14 2","pages":"Pages 41-47"},"PeriodicalIF":0.0,"publicationDate":"2015-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.eii.2015.06.002","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"137161896","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Alelo de riesgo ATG16L1 y estrés del retículo endoplásmico de las células de Paneth en la enfermedad de Crohn inactiva 非活动性克罗恩病中Paneth细胞内质网ATG16L1危险等位基因与应激
Enfermedad Inflamatoria Intestinal al Día Pub Date : 2015-05-01 DOI: 10.1016/j.eii.2015.05.003
E. Cerrillo, B. Beltrán
{"title":"Alelo de riesgo ATG16L1 y estrés del retículo endoplásmico de las células de Paneth en la enfermedad de Crohn inactiva","authors":"E. Cerrillo,&nbsp;B. Beltrán","doi":"10.1016/j.eii.2015.05.003","DOIUrl":"10.1016/j.eii.2015.05.003","url":null,"abstract":"","PeriodicalId":100473,"journal":{"name":"Enfermedad Inflamatoria Intestinal al Día","volume":"14 2","pages":"Pages 72-73"},"PeriodicalIF":0.0,"publicationDate":"2015-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.eii.2015.05.003","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90121460","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
SMAD7: un oligonucleótido antisentido oral para el tratamiento de la enfermedad de Crohn SMAD7:一种口服反义寡核苷酸，用于治疗克罗恩病
Enfermedad Inflamatoria Intestinal al Día Pub Date : 2015-05-01 DOI: 10.1016/j.eii.2015.07.001
A. Hadad
{"title":"SMAD7: un oligonucleótido antisentido oral para el tratamiento de la enfermedad de Crohn","authors":"A. Hadad","doi":"10.1016/j.eii.2015.07.001","DOIUrl":"10.1016/j.eii.2015.07.001","url":null,"abstract":"","PeriodicalId":100473,"journal":{"name":"Enfermedad Inflamatoria Intestinal al Día","volume":"14 2","pages":"Pages 39-40"},"PeriodicalIF":0.0,"publicationDate":"2015-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.eii.2015.07.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75362703","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Medicina alternativa y complementaria en la enfermedad inflamatoria intestinal 炎症性肠病的替代和补充医学
Enfermedad Inflamatoria Intestinal al Día Pub Date : 2015-05-01 DOI: 10.1016/j.eii.2015.06.006
N. Manceñido Marcos
{"title":"Medicina alternativa y complementaria en la enfermedad inflamatoria intestinal","authors":"N. Manceñido Marcos","doi":"10.1016/j.eii.2015.06.006","DOIUrl":"10.1016/j.eii.2015.06.006","url":null,"abstract":"<div><p>The use of Complementary and Alternative Medicine (CAM) in Inflammatory Bowel Disease (IBD) patients is very common. Complementary and alternative therapies might be effective for the treatment of IBD, although they might be as well potentially dangerous. Nowadays, the evidence and information about these types of therapies are not enough. However, alternative treatment strategies are limited and require extensive clinical testing before being optimized for use in patients. Therefore, physicians should know and increasingly inform IBD patients about benefits and limitations of CAM treatment. A review of clinical evidence available on the different types of CAM used in IBD is made.</p></div>","PeriodicalId":100473,"journal":{"name":"Enfermedad Inflamatoria Intestinal al Día","volume":"14 2","pages":"Pages 57-64"},"PeriodicalIF":0.0,"publicationDate":"2015-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.eii.2015.06.006","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87232092","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信